Browsing: transition to CEO

For the full year ended June 30, 2022, EABL reported EABL delivered its highest profit in five years of US$15.6 million, up 124 per cent.

EABL navigated rising inflation and increase in excise taxes through strategic pricing and effective cost management to post impressive figures.

Prior to his role at KBL, Musunga had a highly successful career at GSK working at senior levels in Eastern Africa, Southern Africa, and Europe.

Among other industry roles, he served as a Non-Executive Director for the Vision 2030 Board in Kenya, chaired the Kenya Association of Pharmaceuticals Industry and the Kenya HIV/AIDS Business Council.